Chitoheptaose

Overview

Chitoheptaose is an orally active chitooligosaccharide (degree of polymerization = 7). Chitoheptaose can be extracted from the exoskeletons of crustaceans, such as the shells of crabs, shrimps and lobsters. Chitoheptaose reduces pro-inflammatory cytokines while increasing the levels of anti-inflammatory cytokines (decreasing the levels of pro-inflammatory cytokines IL-1β , IL-17A and IFN-γ , and increasing the level of the anti-inflammatory cytokine IL-10 ). Chitoheptaose possesses antioxidant, anti-inflammatory and anti- Apoptotic activities. Chitoheptaose improves cardiac parameters, alleviates myocarditis injury, and exerts cardioprotective effects in a rat model of myocarditis. Chitoheptaose can be used in studies related to myocarditis.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Heart Disease | Products > Disease Areas > Cardiomyopathy | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Biochemical Assay Reagents | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Interleukin Related | Products > Signaling Pathways > IFNAR

Product Information

• Catalog No.: HY-W145695
• CAS No.: 68232-35-9
• Molecular Formula: C42H79N7O29
• Molecular Weight: 1146.11
• Purity: 99.98%
• Storage: -20°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

Source

Original product source